SRX 0.00% 17.5¢ sierra rutile holdings limited

Immunotherapy, page-6

  1. 1,255 Posts.
    lightbulb Created with Sketch. 12
    Slashj, you are right for overall CRC this is about 15-20%, but these tumours have a better prognosis and are less likely to develop mets, 4% rate in mCRC population.
 
watchlist Created with Sketch. Add SRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.